ArriVent BioPharma (AVBP) is a cautious BUY, driven by furmonertinib’s late-stage potential in uncommon EGFR-mutant NSCLC and ...
In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...
The gray-market drugs flooding Silicon Valley reveal a community that believes it can move faster than the F.D.A.
The State Common Entrance Test Cell, Maharashtra, is likely to start the registration process for the Maharashtra Common ...
Krishang Joshi from Maharashtra bagged an AIR 3 in NEET UG 2025 first attempt. Read on to know his preparation strategy, ...
As 2025 slips into the history books, it leaves behind a year of noise, anxiety, and uneasy optimism. Mint’s reporters and ...
MIT scientists have achieved the first-ever lab synthesis of verticillin A, a complex fungal compound discovered in 1970. Its delicate structure stalled chemists for decades, despite differing from ...
MedPage Today on MSN
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
Interesting Engineering on MSN
7 advances in medicine from 2025 that offered new hope for severe diseases
Scientists and clinicians reported advances that addressed conditions once thought irreversible, from congenital deafness and ...
5don MSN
NITI Aayog report on globalisation of higher education lauds Gujarat's early push through GBU
Gandhinagar: A recent NITI Aayog report on the globalisation of higher education has praised the Gujarat government's ...
The report shows a "three-year retrospective analysis of district metrics, offering a holistic view of performance and ...
School officials say that’s the best possible solution because the virtual teachers are well qualified and keep students on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results